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Abstract: 
The objective of this hospital-based  and prospective study was to compare the outcome of 
endoscopic variceal sclerotherapy and band ligation regarding early and late rebleeding. 
Oesophagealvariceal bleeding is the most common cause of upper gastrointestinal tract 
haemorrhage. Patients with oesophageal variceal bleeding have higher rates of rebleeding, 
complications, and death than patients with non-variceal bleeding such as ulcer bleeding(1). 
Between the year Dec. 2016 –Apr. 2017 a total of 140 patients were reviewed. Variables 
selected for the study included: intervention type: whether it was sclerotherapy or banding 
, OGD findings at presentation, presence of shock upon presentation, duration of having 
the disease before the intervention and outcome of each procedure . Males were (110) 
females (40). The Majority of patients presented with hematemesis and melena (74.28  %), 
hematemesis alone  occurred in (28.57%) and melena alone in ( 7.14%) of patients. All 
patients were diagnosed as portal hypertension due to PPF (Belharziasis) and most of them 
were from Gezira State.  Most of the patients  had portal hypertension  for more than two 
years (41.4%). Sixty patients presented with different stages of shock (42.9%).Sengestaken 
tube was used to control bleeding in (5%) of patients. On the other hand 79.4% of patients 
received blood during resuscitation. Regarding OGD findings, nearly all patients were 
found to have OV alone (97.6). Previously only six patients underwent splenectomy, three 
between 1-2 years, one before five years and one in less than one year. Of the 140 patients 
(49.3%) were treated with Sclerotherapy and (50.7%) underwent band ligation. With regard 
to rebleeding, of those who were treated with Sclerotherapy, (14.49%) of patients rebled 
early, (26.09%) rebled late, (49.28%) did not rebleed and seven patients lost their follow 
up. Comparing to Sclerotherapy, re bleeding in band ligation were found early in(15.95%), 
( 23.19%) presented as late, (57.97%) did not rebled and two patients lost the follow up..  
In conclusion: Treatment of oesophageal variceal bleeding with band ligation has lower 
rates of re-bleeding. Chronicity of portal hypertension appears to be a significant risk factor 
for re-bleeding after both procedures. 
Key words: Oesophagealvariceal, Hematemesis, sclerotherapy, band ligation;portal 
hypertension, Oesophago-gastro-duodenoscopy (OGD), Sudan 
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Introductin: 
Oesophagealvariceal bleeding is the most common (as many as 30%) in all patients presenting with 
upper gastrointestinal tract haemorrhage (1). Acute oesophagealvariceal bleeding is an intractable 
complication of portal hypertension. Patients with oesophagealvariceal bleeding have higher rates of 
rebleeding, complications, and death than patients with non-variceal bleeding such as ulcer bleeding 
(2). Traditional measures have included balloon tamponade, vasoconstrictors, and surgical 
intervention, but these measures did not significantly reduce the rate of rebleeding, complications 
and improve survival.  
Endoscopy has the advantage of allowing specific therapy at the time of diagnosis; it is also 
important to exclude bleeding from other sources (e.g. peptic ulceration).  Variceal 
haemorrhage maybe treated endoscopically, either by injection sclerotherapy or by band 
ligation. 
Here in Sudan endoscopic injection sclerotherapy is an essential component in the management of 
bleeding oesophageal varices caused by portal hypertension. It is a feasible and a cost-effective 
therapeutic strategy, but other options for treatment such as variceal banding are either expensive or 
unavailable in all centres (3) . Endoscopic band ligation is regarded as the main therapeutic option for 
acute oesophageal variceal bleeding, while sclerotherapy may be used in the acute setting if ligation 
is technically difficult. Unfortunately there are no reported or published papers about the experience, 
efficacy or complications of variceal band ligation to confirm its superiority to sclerotherapy in 
Sudan. 
 
Methodology: 
This was a prospective hospital based study conducted at National Centre for Gastrointestinal and 
Liver Disease, Ibn-Sina Specialized Hospital. during the period from Dec 2016 – April 2017. A total 
of 140 patients were reviewed. All the subjects were patients with portal hypertension presenting 
with acute variceal haemorrhage secondary to  schistosomal periportal fibroses, patients excluded 
were the  patients diagnosed with any other cause of Upper Gastrointestinal Bleeding rather than 
variceal bleeding from schistosomal periportal fibroses, and patients who died during resuscitation 
before endoscopy . Verbal and written consents were obtained. The 140 patients were randomly 
assigned into two groups , sclerotherapy group and band ligation group. All patients underwent 
endoscopy by different operators, whenever hemodynamic stability was achieved. The plan of 
whether to do sclerotherapy or band ligation was taken at the timing of endoscopy,  with no specific 
criteria for that .The endoscopic tower used was FUJINON   with 2.5% ethanolamine-oleate used for 
injection sclerotherapy , and standard rubber band used for band ligation .   Analysis  of  data  was  
done  by Microsoft Excel  and comparison  between groups   was  done  by  Statistical Package  of 
Social  Sciences version 20 to calculate  means and  find the levels  of statistical  differences:  the P 
value of < 0.05 was considered to be significant. 
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Results: 
Recruited patients were 140 with mean age of 46.24. with a (3.6:1) male to female ratio, all 
patients were diagnosed as portal hypertension duo to PPF (bilharziasis) and most of them 
were from Gezira State with disease duration less than 6 months in (4.3%), (17.1%) from 
6 months to one year,(37.1%) between 1-2 years and (41.4%) more than two years. 
In this study 96.4% of patients presented with hematemesis and 64.7% with melaena and 
64.7 with both .Fig 1. 
Sixty patients presented with different stages of shock (42.9%) and (77.1%) of patients 
presented with normal vital sings 
 
 
Fig(1): Showing the presenting complains 
 
Regarding OGD findings,(97.6%) were found to have oesophageal varices (OV) alone, 
(15.3%) OV and JV, (2.2%) junctional varices (JV), (1.5%) FV, (0.7%) OV with FV and 
(0.7%) had OV plus JV and FV. Fig 2 
 
 
Fig(2): Showing the endoscopy findings 
 
Previously only six patients underwent splenectomy, three between 1-2 years, one before 
five year and one less than one year. 
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Of the 140 patients (49.3%) were treated with Sclerotherapy and (50.7%) underwent band ligation. 
With regard to rebleeding, of those who were treated with Sclerotherapy, (14.49%) of patients rebled 
early, (26.09%) rebled late, (49.28%) did not re bleed and seven patients were lost to  follow up. 
Compared to Sclerotherapy, re bleeding in band ligation was found early in(15.95%), ( 23.19%) 
presented as late, (57.97%) did not bleed and two patients were lost to follow up. (Table 1). 
Table(1): Showing Endoscopic Intervention and the Time of re-Bleeding 
 Early Late Total number p 
Sclerotherapy 14.49% 26.09% 28 0.47 
Banding 15.94% 23.19% 27 0.58 
Both  
sclerotherapy 
and banding 
0% 2.86% 1 0.99 
 
Discussion: 
Oesophagealvariceal bleeding is the most common cause of upper gastrointestinal tract 
haemorrhage(1). This study compared the outcome of endoscopic varicealsclerotherapy versus band 
ligation regarding early and late re bleeding , We considered having two comparison groups in the 
determination of sample size , since we had two parameters for each sub-group the size of the sample 
was sufficient to have 95% confidence level and 5% margin of error.  
140 patients were admitted with acute variceal bleeding all of them due to portal hypertension. From 
this study it was observed that portal hypertension due to   schistosomiasis constituted the bulk of 
the problem which goes well with the literature  as to Moawiaalbalal et al , found that 93% of patients 
admitted in a GIT center in Medani with variceal bleeding were having portal  hypertension due to 
schistosomiasis(2 ). Another data from Mohammed Salih Idris center showed that 77% of bleeding 
was variceal in origin.(4) 
The experience with sclerotherapy in Sudan is well established. Baha et al under the title  
"Endoscopic sclerotherapy experience in  Sudan" which reviewed 1070 patients with 10 years 
duration, proved that endoscopic sclerotherapy was essential and cost-effective for the management 
of bleeding oesophagealvarices(4) . Although band ligation is widely performed now and it is also 
feasible and has less complications regarding rebleeding. There was no published papers regarding 
experience with band ligation in Sudan . In our study 15% of patients developed early rebleeding, 
and 18% developed late rebleeding, in the contrary to Abdolmonium et al  who concluded that 5days 
– 6weeks rebleeding was 32% and 3% respectively in patients with ppf and osaphgealvariceal 
bleeding in the same center(5). 
Table (1) compares the efficacy of both endoscopic sclerotherapy and band ligation regarding early 
and late rebleeding, of all patients who had early rebleeding, (47.61%) of them had sclerotherapy, 
(52.39%) had band ligation and no one developed early rebleeding after both procedure. And of those 
who had late bleeding (51.43%) of them underwent sclerotherapy, (45.33%) band ligation and 
(2.87%) both procedure. Forty patients out of sixty nine (57.97%) who underwent band ligation and 
34 patients out of 69 (49.28%)  who underwent sclerotherapy did not experience hematamesis or 
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melaena in the 6 months duration of follow up. In this study Endoscopic Band Ligation was superior 
to Endoscopic Injection Sclerotherapy for avoidance of rebleeding. G. E. Esmat et al. conducted a 
meta-analysis for compression between the Endoscopic Band Ligation versus the Endoscopic 
Injection Sclerotherapy  groups and found that recurrence of bleeding was significantly less in the 
Endoscopic Band Ligation versus the Endoscopic Injection Sclerotherapy groups (24.2% versus 
42.9%; p 0.04). In addition. Lo et al also., re- ported 17% rate of re-bleeding with Endoscopic Band 
Ligation vs. 33% with Endoscopic Injection Sclerotherapy(6) .Villanueva et al. , reported 12% 
incidence rate for re-bleeding for Endoscopic Band Ligation  versus 21% for Endoscopic Injection 
Sclerotherapy(7). The results reflected the good quality of endoscopic management of 
eosaphgealvarices , whether it was banding or sclerotherapy although band ligation was superior to 
sclerotherapy. 
Table (2) shows observed that  the presence of shock was associated with increased likely hood of 
rebleeding in both groups  with a statistical significance  .but this seems to be less reproducible 
between other literature .   
 
Table(2): Showing the Status of Shock on Presentation and the Timing of Re-Bleeding 
 Early rebleeding Late  Re-
bleeding 
Total number p 
Shock 61.90% 62.9% 35 0.64 
No Shock 38.09% 37.1% 21 0.53 
 
Table (3), shows having the disease for more than one year will increase the risk of rebleeding by 
two folds. Similarly Ibrahim sz et. al studied the risk factors for bleeding in patints with symptomatic 
oseophealvarices secondary to schistosomal portal hypertension , and found that chronicity of the 
disease appers to be a significant factor in that the bleeders had longer duration than non bleeders 
(80% vs 37.5% p<0.01)(8). 
 
Table (3): Relation of the disease duration on presentation to the timing of re-Bleeding 
 Early  Re-
bleeding 
late Re-bleeding Total p 
Short Duration 6.76% 14.3% 7 0.29 
Long Duration 87.7% 90.84% 49 0.32 
 
Conclusion: 
 Sclerotherapy is the standard first line therapy for patients with 
eosaphagealvaricesbleeding , band ligation maybe more difficult to perform 
specially during active bleeding , but has proven more efficacy in treating 
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eosaphagelvarices for 6 months.  Treatment of esophageal variceal bleeding with 
band ligation has lower rates of early and late  rebleeding.  
 Chronicity of portal hypertension appears to be a significant risk factor for re bleeding 
after both procedures. Presence of shock at presentation was associated with increased 
likely hood of re bleeding after both procedures. 
 We recommend that conducting  a further large scale randomized controlled trials to 
be done. It will be helpful in firmly establishing the efficacy of EVL for patients with 
esophageal variceal bleeding. 
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